IN C037
Alternative Names: IN-C037Latest Information Update: 05 Aug 2022
At a glance
- Originator HK inno.N
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Cancer
Most Recent Events
- 29 Jul 2022 Early research in Cancer in South Korea (unspecified route) (HK inno.N pipeline; July 2022)